斑塊切除設備市場：市場規模（按細分市場）、份額、監管、報銷、程序、預測（~2033）

冠狀動脈疾病（CAD）正在成為發展中國家和已開發國家的全球負擔。週邊動脈疾病（PAD）是一個全球性的公共衛生和社會經濟問題，每年影響數百萬患者。由於糖尿病、高血壓、肥胖和吸煙等危險因子和合併症，全世界 CAD 和 PAD 的盛行率正在增加。

整體而言，都市化導致吸菸率上升、缺乏身體活動和不健康的生活方式。此外，老年人口的增長也導致疾病盛行率上升，因為許多合併症與年齡密切相關。

該報告深入探討了全球旋切設備市場，包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響以及區域和國家趨勢。

目錄

目前市面上的旋切設備及競爭狀況

• 洞察關鍵產業趨勢
• 2015年至2033年斑塊切除設備各細分市場的市場總收入及市場前景
• 按細分市場劃分的程序總數、單位數、平均售價和市場價值的詳細數據

全球、區域和國家見解

• 斑塊切除設備市場的 SWOT 分析
• 斑塊切除設備市場的競爭動態洞察與趨勢
• 按國家/地區劃分的醫療保健系統概覽
• 各國報銷政策
• 各國醫療技術法規現狀

Abstract

Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Atherectomy Devices market for the year 2020 and beyond. Coronary Artery Disease (CAD) has emerged as a global burden on developing and developed countries. Peripheral artery disease (PAD) is a global public health and socioeconomic problem affecting millions of patients each year. The increasing prevalence of both CAD and PAD worldwide can be attributed to risk factors and comorbidities such as diabetes, hypertension, obesity, and tobacco use.

Overall, urbanization has led to increased smoking rates, lack of physical activity and unhealthy lifestyle. Moreover, as many of these comorbidities are closely tied to age, the growing elderly population will also contribute to the rising disease prevalence.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Atherectomy Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Atherectomy Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Atherectomy Devices market.
• Competitive dynamics insights and trends provided for Atherectomy Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Cardiovascular Systems Inc, Boston Scientific Corp, Koninklijke Philips NV, Medtronic Plc, Avinger Inc, Becton Dickinson and Co, Angiodynamics Inc.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Atherectomy Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Atherectomy Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Atherectomy Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Atherectomy Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Atherectomy Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable